{"id":"https://openalex.org/W39898859","doi":null,"title":"NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.","display_name":"NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.","publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W39898859","mag":"39898859","pmid":"https://pubmed.ncbi.nlm.nih.gov/19066411"},"language":"en","primary_location":{"id":"pmid:19066411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021937022","display_name":"Ewa Poleszak","orcid":"https://orcid.org/0000-0003-4359-3953","observed_orcids":["https://orcid.org/0000-0003-4359-3953"]},"institutions":[{"id":"https://openalex.org/I121032520","display_name":"Medical University of Lublin","ror":"https://ror.org/016f61126","country_code":"PL","type":"education","lineage":["https://openalex.org/I121032520"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Ewa Poleszak","raw_affiliation_strings":["Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Staszica 4, PL 20-081 Lublin, Poland. ewa.poleszak@am.lublin.pl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Pharmacodynamics, Medical University of Lublin, Staszica 4, PL 20-081 Lublin, Poland. ewa.poleszak@am.lublin.pl","institution_ids":["https://openalex.org/I121032520"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036187783","display_name":"Piotr W\u0142a\u017a","orcid":"https://orcid.org/0000-0002-5389-0241","observed_orcids":["https://orcid.org/0000-0002-5389-0241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piotr Wla\u017a","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081903016","display_name":"Andrzej Wr\u00f3bel","orcid":"https://orcid.org/0000-0002-5772-0573","observed_orcids":["https://orcid.org/0000-0002-5772-0573"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrzej Wr\u00f3bel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067219976","display_name":"Sylwia Fidecka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylwia Fidecka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044015773","display_name":"Gabriel Nowak","orcid":"https://orcid.org/0000-0002-3000-7938","observed_orcids":["https://orcid.org/0000-0002-3000-7938","https://orcid.org/0000-0003-4864-7164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gabriel Nowak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.6249,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.79634276,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"60","issue":"5","first_page":"655","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.6079000234603882,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12280","display_name":"Magnesium in Health and Disease","score":0.25270000100135803,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.06419999897480011,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/magnesium","display_name":"magnesium","score":0.9589999914169312},{"id":"https://openalex.org/keywords/anxiolytic-like-behavior","display_name":"anxiolytic-like behavior","score":0.9679999947547913},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.7260000109672546},{"id":"https://openalex.org/keywords/nmda-receptor","display_name":"NMDA receptor","score":0.906000018119812},{"id":"https://openalex.org/keywords/glutamate","display_name":"glutamate","score":0.628000020980835},{"id":"https://openalex.org/keywords/d-serine","display_name":"D-serine","score":0.8679999709129333},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7260000109672546},{"id":"https://openalex.org/keywords/cgp-37849","display_name":"CGP 37849","score":0.8830000162124634},{"id":"https://openalex.org/keywords/l-701-324","display_name":"L-701,324","score":0.9440000057220459},{"id":"https://openalex.org/keywords/d-cycloserine","display_name":"D-cycloserine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/mk-801","display_name":"MK-801","score":0.9959999918937683},{"id":"https://openalex.org/keywords/elevated-plus-maze","display_name":"elevated plus maze","score":0.8379999995231628}],"concepts":[{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.890641987323761},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7707109451293945},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.763351321220398},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7210050225257874},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7077482342720032},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.705595850944519},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6238122582435608},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.6063612103462219},{"id":"https://openalex.org/C2777836312","wikidata":"https://www.wikidata.org/wiki/Q4386371","display_name":"Dizocilpine","level":4,"score":0.4631447494029999},{"id":"https://openalex.org/C543218039","wikidata":"https://www.wikidata.org/wiki/Q660","display_name":"Magnesium","level":2,"score":0.4494122266769409},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.255115807056427},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1686958372592926},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14007288217544556},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.08902692794799805},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000963","descriptor_name":"Antimetabolites","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001224","descriptor_name":"Aspartic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003523","descriptor_name":"Cycloserine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015763","descriptor_name":"2-Amino-5-phosphonovalerate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015763","descriptor_name":"2-Amino-5-phosphonovalerate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016291","descriptor_name":"Dizocilpine Maleate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017470","descriptor_name":"Receptors, Glutamate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018009","descriptor_name":"Receptors, Glycine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018684","descriptor_name":"Glycine Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:19066411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacological reports : PR","raw_type":"Journal Article"},{"id":"mag:39898859","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19066411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W101037913","https://openalex.org/W140157298","https://openalex.org/W148453453","https://openalex.org/W181123659","https://openalex.org/W196902989","https://openalex.org/W1526981538","https://openalex.org/W1532904557","https://openalex.org/W1664478550","https://openalex.org/W1975172072","https://openalex.org/W1979058616","https://openalex.org/W1979367793","https://openalex.org/W1982321231","https://openalex.org/W1989825133","https://openalex.org/W1997401808","https://openalex.org/W1997568797","https://openalex.org/W2012568585","https://openalex.org/W2022192318","https://openalex.org/W2023099208","https://openalex.org/W2023928627","https://openalex.org/W2023979631","https://openalex.org/W2024105385","https://openalex.org/W2030249389","https://openalex.org/W2031432617","https://openalex.org/W2032058764","https://openalex.org/W2035129561","https://openalex.org/W2035305597","https://openalex.org/W2038704879","https://openalex.org/W2038893879","https://openalex.org/W2041561931","https://openalex.org/W2042463748","https://openalex.org/W2062741447","https://openalex.org/W2073117914","https://openalex.org/W2076117152","https://openalex.org/W2081678712","https://openalex.org/W2084873146","https://openalex.org/W2086305648","https://openalex.org/W2086778530","https://openalex.org/W2091354907","https://openalex.org/W2092953670","https://openalex.org/W2094126290","https://openalex.org/W2094531953","https://openalex.org/W2094726567","https://openalex.org/W2094840655","https://openalex.org/W2095412563","https://openalex.org/W2100040827","https://openalex.org/W2115609473","https://openalex.org/W2142324040","https://openalex.org/W2162876973","https://openalex.org/W2249014812","https://openalex.org/W2412064031","https://openalex.org/W2417803326","https://openalex.org/W2434291406","https://openalex.org/W2461895846"],"related_works":["https://openalex.org/W148453453","https://openalex.org/W2077419301","https://openalex.org/W1990894528","https://openalex.org/W859182251","https://openalex.org/W2031432617","https://openalex.org/W2142324040","https://openalex.org/W1995442932","https://openalex.org/W2995813043","https://openalex.org/W2233987578","https://openalex.org/W2019855156"],"abstract_inverted_index":{"The":[0,133],"anxiolytic-like":[1,113,146],"activity":[2,114,147,156],"of":[3,25,42,55,65,86,97,104,109,125,128,139],"magnesium":[4,31,87,145],"in":[5,94,100,143,148,151],"mice":[6],"during":[7],"the":[8,18,23,30,34,56,66,73,95,101,105,129,137,140,144,149,159],"elevated":[9],"plus":[10],"maze":[11,106],"(EPM)":[12],"has":[13],"been":[14],"demonstrated":[15,37],"previously.":[16],"In":[17],"present":[19,134],"study,":[20],"we":[21],"examined":[22],"involvement":[24,138],"NMDA/glutamate":[26,141],"receptor":[27,131],"ligands":[28],"on":[29,33],"effect":[32],"EPM.":[35],"We":[36],"that":[38,154],"low,":[39],"ineffective":[40,84],"doses":[41],"NMDA":[43,47,75,130],"antagonists":[44],"(the":[45],"competitive":[46],"antagonist":[48,54,76],"CGP":[49],"37849,":[50],"0.3":[51],"mg/kg;":[52,61,71],"an":[53,83,123],"glycineB":[57,67,126,160],"sites,":[58,68],"L-701,324,":[59],"1":[60],"a":[62,91],"partial":[63],"agonist":[64,124],"D-cycloserine,":[69],"2.5":[70],"and":[72,153],"non-competitive":[74],"MK-801,":[77],"0.05":[78],"mg/kg)":[79,89,116],"administered":[80],"together":[81],"with":[82],"dose":[85],"(10":[88],"evoked":[90],"significant":[92],"increase":[93],"percentage":[96],"time":[98],"spent":[99],"open":[102],"arm":[103],"(an":[107],"index":[108],"anxiety).":[110],"Moreover,":[111],"magnesium-induced":[112],"(20":[115],"was":[117],"antagonized":[118],"by":[119],"D-serine":[120],"(100":[121],"nmol/mouse),":[122],"site":[127],"complex.":[132],"study":[135],"demonstrates":[136],"pathway":[142],"EPM":[150],"mice,":[152],"this":[155],"particularly":[157],"involves":[158],"sites.":[161]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":9},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}